SLNO Soleno Therapeutics, Inc.

$53.01▲ +0.00% Unknown Other
Volume 4.97M Avg Volume (10D)
Key Metrics & Fundamentals
Market Cap
$2.76B
P/E Ratio
27.5
Div Yield
–%
52W Range
29.43 - 90.32
% vs 50 MA
15.77%
% vs 200 MA
1.17%
RSI-14
77.7
MACD Histogram
-0.5000
Beta (1Y vs SPY)
1.14
Free Cash Flow
$25.94M
Gross Rev
$94.60M
Gross Profit
$93.41M
EBITDA
$37.20M
COGS
$1.20M
Operating Exp
$61.64M
Operating Income
$31.76M
EBIT
$31.76M
Pretax Income
$34.91M
Net Income
$31.38M
EPS (Diluted)
0.59
Price & Volume History
Loading chart…
Recent News
No recent news found for SLNO.
Financial Overview - Income Statement Quarterly

See SLNO's money flow as a full page

AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙